May 2026 • PharmaTimes Magazine • 3
In politics and in pharma, as in life itself, the forbidden fruit of instant gratification is ubiquitous and, even knowing about the acridity beneath its shallow veneer, we so often make ourselves oblivious to its deadly presence.
Our eyes are seduced – they start rotating like kaleidoscopic spiralled lollies at a hypnotic fairground – and, at that crucial moment, all we can see is colour such as no palette has ever hosted before.
Opting for the radiance of the moment rather than the clarity of consequence happens when people are convinced by economic ignition or deafening applause or an untouchable conviction in themselves to make decisions.
And these judgements unfold in a portal that exists outside common knowledge, involving things that are embarrassingly obvious to literally everyone else.
But the forbidden fruit starts to rot at extraordinary speed. The primrose path that Peter Mandelson and Keir Starmer skipped down is now a burnt-out wasteland dotted with dystopian signs that hint at the horror.
Pharma has its own history. Opioids, without due care, can quickly emerge as the Mandelson of the medicine cabinet. A way to ‘get in there’, appear to expunge the pain, before becoming seemingly indispensable.
Life sciences wider history shows that a positive legacy happens when you don’t get distracted by a low-hanging crowd-pleaser but when data, trials and patients combine to big up life in a way that inspires delight not disdain.
Enjoy the mag,
editor
PharmaTimes Media Ltd,
44 Maiden Lane
Covent Garden
London
WC2E 7LN
Tel: +44 (0)20 7240 6999
pharmatimes.com
Twitter: @PharmaTimes
MAGAZINE
John Pinching / editor
john.pinching@pharmatimes.com
Michelle Legrand / sales manager
michelle.legrand@pharmatimes.com
COMPETITIONS
Luci Sargood / business manager
luci.sargood@pharmatimes.com
Michelle Legrand / sales manager
michelle.legrand@pharmatimes.com
James Tansill / Marketing Executive
james.tansill@pharmatimes.com
PMGROUP
Tara Lovegrove / business director
tara.lovegrove@pharmatimes.com
Iona Everson / group managing editor
iona.everson@pharmatimes.com
Karl Equi / executive director
karl.equi@pharmatimes.com
SUBSCRIPTIONS/REPRINTS
Digital and paper copies available
free to qualifying readers:
www.pharmatimes.com/subscribe
Tel: 01372 414 222
subscriptions@pharmatimes.com
Paper subscriptions available at £90.00 UK
and £100.00 overseas per annum.
Views expressed by the contributors
do not necessarily represent those of
the publisher, editor or staff.
Material may not be reproduced in any form
without the publisher’s written permission.
© Copyright 2025 PharmaTimes Magazine.
All rights reserved. PharmaTimes Magazine
is published by PharmaTimes Media Ltd,
which is registered as a limited company
in England; No 09019637.